BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 20232485)

  • 1. The role of chromosome 21 in hematology and oncology.
    Fonatsch C
    Genes Chromosomes Cancer; 2010 Jun; 49(6):497-508. PubMed ID: 20232485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trisomy of chromosome 21 in leukemogenesis.
    Izraeli S; Rainis L; Hertzberg L; Smooha G; Birger Y
    Blood Cells Mol Dis; 2007; 39(2):156-9. PubMed ID: 17532652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AML1/RUNX1 mutations are infrequent, but related to AML-M0, acquired trisomy 21, and leukemic transformation in pediatric hematologic malignancies.
    Taketani T; Taki T; Takita J; Tsuchida M; Hanada R; Hongo T; Kaneko T; Manabe A; Ida K; Hayashi Y
    Genes Chromosomes Cancer; 2003 Sep; 38(1):1-7. PubMed ID: 12874780
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Association of congenital chromosome abnormalities and malignant diseases].
    Erzsébet B; Andrea N; Róbert S; Eva O
    Orv Hetil; 1996 Feb; 137(5):227-31. PubMed ID: 8882440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Constitutional chromosome abnormalities and acute leukemia].
    Turc-Carel C; Mugneret F; Sidaner I
    Pathol Biol (Paris); 1982 Nov; 30(9):792-7. PubMed ID: 6218469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The AML1 gene: a transcription factor involved in the pathogenesis of myeloid and lymphoid leukemias.
    Lo Coco F; Pisegna S; Diverio D
    Haematologica; 1997; 82(3):364-70. PubMed ID: 9234595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of acute lymphoblastic leukemia in Down syndrome and non-Down syndrome children: the role of trisomy 21.
    Tigay JH
    J Pediatr Oncol Nurs; 2009; 26(6):362-8. PubMed ID: 20032297
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Unique clinical and biological features of leukemia in Down syndrome children.
    Xavier AC; Ge Y; Taub J
    Expert Rev Hematol; 2010 Apr; 3(2):175-86. PubMed ID: 21083461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leukemia in infants.
    Felix CA; Lange BJ
    Oncologist; 1999; 4(3):225-40. PubMed ID: 10394590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Constitutional chromosome anomalies and acute leukemia].
    Turc-Carel C; Mugneret F; Sidaner I
    Sem Hop; 1983 Sep; 59(32):2267-72. PubMed ID: 6314516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down syndrome--a gene dosage disease caused by trisomy of genes within a small segment of the long arm of chromosome 21, exemplified by the study of effects from the superoxide-dismutase type 1 (SOD-1) gene.
    Annerén G; Edman B
    APMIS Suppl; 1993; 40():71-9. PubMed ID: 8311993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down syndrome, drug metabolism and chromosome 21.
    Taub JW; Ge Y
    Pediatr Blood Cancer; 2005 Jan; 44(1):33-9. PubMed ID: 15390307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duplication and loss of chromosome 21 in two children with Down syndrome and acute leukemia.
    Rogan PK; Close P; Blouin JL; Seip JR; Gannutz L; Ladda RL; Antonarakis SE
    Am J Med Genet; 1995 Nov; 59(2):174-81. PubMed ID: 8588582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Familial platelet disorder with propensity to acute myelogenous leukemia: genetic heterogeneity and progression to leukemia via acquisition of clonal chromosome anomalies.
    Minelli A; Maserati E; Rossi G; Bernardo ME; De Stefano P; Cecchini MP; Valli R; Albano V; Pierani P; Leszl A; Sainati L; Lo Curto F; Danesino C; Locatelli F; Pasquali F
    Genes Chromosomes Cancer; 2004 Jul; 40(3):165-71. PubMed ID: 15138996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Marker chromosomes are a significant mechanism of high-level RUNX1 gene amplification in hematologic malignancies.
    Moosavi SA; Sanchez J; Adeyinka A
    Cancer Genet Cytogenet; 2009 Feb; 189(1):24-8. PubMed ID: 19167608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pattern of trisomy 1q in hematological malignancies: a single institution experience.
    Djordjević V; Dencić-Fekete M; Jovanović J; Drakulić D; Stevanović M; Janković G; Gotić M
    Cancer Genet Cytogenet; 2008 Oct; 186(1):12-8. PubMed ID: 18786437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GATA1 mutations in acute leukemia in children with Down syndrome.
    Magalhães IQ; Splendore A; Emerenciano M; Figueiredo A; Ferrari I; Pombo-de-Oliveira MS
    Cancer Genet Cytogenet; 2006 Apr; 166(2):112-6. PubMed ID: 16631466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 7 abnormalities in acute megakaryoblastic leukemia associated with Down syndrome.
    Kobayashi K; Usami I; Kubota M; Nishio T; Kakazu N
    Cancer Genet Cytogenet; 2005 Apr; 158(2):184-7. PubMed ID: 15796967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectral karyotyping in patients with acute myeloid leukemia and a complex karyotype shows hidden aberrations, including recurrent overrepresentation of 21q, 11q, and 22q.
    Mrózek K; Heinonen K; Theil KS; Bloomfield CD
    Genes Chromosomes Cancer; 2002 Jun; 34(2):137-53. PubMed ID: 11979548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trisomy 21 in neoplastic cells.
    Mitelman F; Heim S; Mandahl N
    Am J Med Genet Suppl; 1990; 7():262-6. PubMed ID: 2149959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.